Oladapo Yeku

Dr. Oladapo Yeku is an Assistant Professor of Medicine at Harvard Medical School and the Director of Translational Research for the Gynecologic Oncology Program at the Massachusetts General Hospital. He is an Associate Editor at NEJM Evidence. Dr. Yeku completed his Medical Oncology fellowship training at Memorial Sloan Kettering Cancer Center (MSKCC) and is an expert on immunotherapy for gynecologic cancers. Dr. Yeku is actively involved as a Principal Investigator in early-phase drug development, immunotherapy clinical trials, and adoptive cellular therapy clinical trials. His laboratory studies the immunosuppressive tumor microenvironment in Gynecologic Cancers and develops immunotherapeutic approaches such as bispecific T-cell engagers and Chimeric Antigen Receptor (CAR) T-cells to overcome these obstacles.